Article
Data reuse enables cost-efficient randomized trials of medical AI models
2025-12-02
Abstract excerpt
<title>Abstract</title> <p>Randomized controlled trials (RCTs) are indispensable for establishing the clinical value of medical artificial-intelligence (AI) tools, yet their high cost and long timelines hinder timely validation as new models emerge rapidly. Here, we propose BRIDGE, a data-reuse RCT design for AI-based risk models. AI risk models support a broad range of interventions, including screening, treatme...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 00985997-1d4f-56ec-9e27-a0233a92a82b
- DOI
- 10.21203/rs.3.rs-8092084/v1
